Recent analysis by America’s Health Insurance Plans shows that Big Pharma companies in the US tend to spend more on sales and marketing than on R&D. 



The challenge is becoming more acute. As drugs become ever more targeted, the market for each drug becomes smaller and the value of a single patient grows. Finding the right patient and gaining their prescription is an essential battle to win. Can AI make a difference?